Skip to main content

Epidemiology of Diabetes

  • Chapter
  • First Online:
Dermatology and Diabetes

Abstract

Diabetes mellitus is a chronic, metabolic disease defined by increased concentrations of blood glucose which leads, over time, to progressive damage in most tissues and organs including heart, blood vessels, eyes, kidneys, skin, and nerves. The most common is type 2 diabetes, commonly in adults, which occurs as result of the combination of insulin resistance with pancreatic beta cell insufficiency, with 50% of patients requiring insulin treatment within 10 years [1]. Type 1 diabetes, more frequent in children and adolescents, is a chronic autoimmune disease in which autoreactive T lymphocytes and inflammation cause severe loss of beta cells [2]. The incidence of diabetes exhibits an alarming pandemic scenario, in large part due to the global obesity epidemic [3]. Diabetes causes premature death, severe disability and great economic burden. Therefore, there is a globally agreed target to stop the growing incidence of diabetes and obesity by 2025 [4].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kahn SE, Cooper ME, Del Prato S. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet. 2014;383(9922):1068–83.

    Article  CAS  PubMed  Google Scholar 

  2. Pugliese A. Advances in the etiology and mechanisms of type 1 diabetes. Discov Med. 2014;18(98):141–50.

    PubMed  Google Scholar 

  3. World Health Organization. Global report on diabetes, Geneva. 2016. Accessed 28 Aug 2017.

    Google Scholar 

  4. United Nations. Resolution 66/2. Political declaration of the high-level meeting of the general assembly on the prevention and control of noncommunicable diseases. In:Sixty-sixth session of the United Nations General Assembly. New York: United Nations; 2011.

    Google Scholar 

  5. World Health Organization. Global status report on noncommunicable diseases 2015. Geneva: World Health Organization; 2015.

    Google Scholar 

  6. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes. Estimates for year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–53.

    Article  PubMed  Google Scholar 

  7. Addo J, Agyemang C, de-Graft Aikins A, Beune E, Schulze MB, et al. Association between socioeconomic position and the prevalence of type 2 diabetes in Ghanaians in different geographic locations: the RODAM study. J Epidemiol Community Health. 2017;71(7):633–9.

    Article  PubMed  PubMed Central  Google Scholar 

  8. WHO mortality database [online database]. Geneva: World Health Organization. http://apps.who.int/healthinfo/statistics/mortality/causeofdeath_query/. Accessed 28 Aug 2017.

  9. Pulgaron ER, Delamater AM. Obesity and type 2 diabetes in children: epidemiology and treatment. Curr Diab Rep. 2014;14(8):508.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Gakidou E, Mallinger L, Abbott-Klafter J, Guerrero R, Villalpando S, et al. Management of diabetes and associated cardiovascular risk factors in seven countries: a comparison of data from national health examination surveys. Bull World Health Organ. 2011;89(3):172–83.

    Article  PubMed  Google Scholar 

  11. Beagley J, Guariguata L, Weil C, Motala AA. Global estimates of undiagnosed diabetes in adults. Diabetes Res Clin Pract. 2013;103(2):150–60.

    Article  PubMed  Google Scholar 

  12. World Health Organization. Diabetes: equity and social determinants. In: Blas E, Kuru A, editors. Equity, social determinants and public health programmes. Geneva: World Health Organization; 2010.

    Google Scholar 

  13. DIAMOND Project Group. Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diabet Med. 2006;23(8):857–66.

    Article  Google Scholar 

  14. Dabelea D. The accelerating epidemic of childhood diabetes. Lancet. 2009;373(9680):1990–2000.

    Article  Google Scholar 

  15. Bendas A, Rothe U, Kiess W, Kapellen TM, Stange T, et al. Trends in incidence rates during 1999-2008 and prevalence in 2008 of childhood type 1 diabetes mellitus in Germany. Model-based national estimates. PLoS One. 2015;10(7):e0132716.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Gupta R, Misra A. Epidemiology of microvascular complications of diabetes in South Asians and comparison with other ethnicities. J Diabetes. 2016;8(4):470–82.

    Article  PubMed  Google Scholar 

  17. United States Renal Data System. International Comparisons. In United States Renal Data System. 2014 USRDS annual data report: epidemiology of kidney disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2014. p. 188–210.

    Google Scholar 

  18. Moxey PW, Gogalniceanu P, Hinchliffe RJ, Loftus IM, Jones KJ, et al. Lower extremity amputations: a review of global variability in incidence. Diabet Med. 2011;28(10):1144–53.

    Article  CAS  PubMed  Google Scholar 

  19. Thomas MC, Cooper ME, Zimmet P. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat Rev Nephrol. 2016;12(2):73–81.

    Article  CAS  PubMed  Google Scholar 

  20. Ting DS, Cheung GC, Wong TY. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Exp Ophthalmol. 2016;44(4):260–77.

    Article  PubMed  Google Scholar 

  21. Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556–64.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Volmer-Thole M, Lobmann R. Neuropthy and diabetic foot syndrome. Int J Mol Sci. 2016;17(6):E917.

    Article  PubMed  Google Scholar 

  23. Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215–22.

    Article  CAS  PubMed  Google Scholar 

  24. Danaei G, Lawes CM, Vander HS, Murray CJ, Ezzati M. Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet. 2006;368(9548):1651–9.

    Article  PubMed  Google Scholar 

  25. Singh GM, Danaei G, Farzadfar F, Stevens GA, Woodward M, et al. The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis. PLoS One. 2013;8(7):e65174.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Atherosclerotic cardiovascular disease and heart failure in type 2 diabetes. Mechanisms, management, and clinical considerations. Circulation. 2016;133(24):2459–502.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Barengo NC, Katoh S, Moltchanov V, Tajima N, Tuomilehto J. The diabetes-cardiovascular risk paradox: results from a Finnish population-based prospective study. Eur Heart J. 2008;29(15):1889–95.

    Article  PubMed  Google Scholar 

  28. Seuring T, Archangelidi O, Suhrcke M. The economic costs of type 2 diabetes: a global systematic review. PharmacoEconomics. 2015;33(8):811–31.

    Article  PubMed  PubMed Central  Google Scholar 

  29. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;387(10027):1513–30.

    Article  Google Scholar 

  30. International Diabetes Federation. IDF diabetes atlas. 6th ed. Brussels: International Diabetes Federation; 2013.

    Google Scholar 

  31. Bloom DE, Cafiero ET, Jané-Llopis E, Abrahams-Gessel S, Bloom LR, et al. The global economic burden of noncommunicable diseases (working paper series). Geneva: Harvard School of Public Health and World Economic Forum; 2011.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mariano Javier Taverna M.D., Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Taverna, M.J. (2018). Epidemiology of Diabetes. In: Cohen Sabban, E., Puchulu, F., Cusi, K. (eds) Dermatology and Diabetes. Springer, Cham. https://doi.org/10.1007/978-3-319-72475-1_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-72475-1_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-72474-4

  • Online ISBN: 978-3-319-72475-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics